WHTCF (WELL Health Technologies) Piotroski F-Score: 6 (As of Jun. 26, 2026) — 50% Above Median


WHTCF WELL Health Technologies Corp WHTCF
76 GF Score
Price $2.91
GF Value $5.16
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is WELL Health Technologies Piotroski F-Score?

WELL Health Technologies WHTCF 76 Piotroski F-Score is 6 as of Jun. 26, 2026, which is 50% above its 10-year median of 4.00. GuruFocus rates WHTCF with a GF Score™ of 76/100 and a GF Value™ of $5.16 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 652 Healthcare Providers & Services companies, WELL Health Technologies ranks better than 74.69% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

WELL Health Technologies has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for WELL Health Technologies's Piotroski F-Score or its related term are showing as below:

WHTCF' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 7
Current: 6

During the past 13 years, the highest Piotroski F-Score of WELL Health Technologies was 7. The lowest was 2. And the median was 4.

WELL Health Technologies  (OTCPK:WHTCF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


WELL Health Technologies Piotroski F-Score Related Terms


WELL Health Technologies Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for WELL Health Technologies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WELL Health Technologies Piotroski F-Score Chart

WELL Health Technologies Annual Data
Trend Oct16 Oct17 Oct18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 7.00 5.00 5.00 6.00

WELL Health Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 2.00 4.00 6.00 6.00

WHTCF vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, WELL Health Technologies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WELL Health Technologies Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WELL Health Technologies's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where WELL Health Technologies's Piotroski F-Score falls into.


WHTCF
76GF Score
WELL Health Technologies Corp WHTCF
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 8.89 + 3.016 + 16.594 + -9.026 = $19 Mil.
Cash Flow from Operations was 19.98 + 19.666 + 33.378 + 10.896 = $84 Mil.
Revenue was 260.955 + 263.553 + 278.92 + 268.412 = $1,072 Mil.
Gross Profit was 116.139 + 119.829 + 128.207 + 118.926 = $483 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(1262.166 + 1477.232 + 1459.502 + 1520.035 + 1578.708) / 5 = $1459.5286 Mil.
Total Assets at the begining of this year (Mar25) was $1,262 Mil.
Long-Term Debt & Capital Lease Obligation was $401 Mil.
Total Current Assets was $276 Mil.
Total Current Liabilities was $334 Mil.
Net Income was 75.659 + -66.524 + 5.645 + -32.442 = $-18 Mil.

Revenue was 165.861 + 172.844 + 164.777 + 204.888 = $708 Mil.
Gross Profit was 66.798 + 69.872 + 58.03 + 81.828 = $277 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(1084.707 + 1194.961 + 1176.087 + 1268.529 + 1262.166) / 5 = $1197.29 Mil.
Total Assets at the begining of last year (Mar24) was $1,085 Mil.
Long-Term Debt & Capital Lease Obligation was $311 Mil.
Total Current Assets was $235 Mil.
Total Current Liabilities was $254 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

WELL Health Technologies's current Net Income (TTM) was 19. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

WELL Health Technologies's current Cash Flow from Operations (TTM) was 84. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=19.474/1262.166
=0.01542903

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-17.662/1084.707
=-0.01628274

WELL Health Technologies's return on assets of this year was 0.01542903. WELL Health Technologies's return on assets of last year was -0.01628274. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

WELL Health Technologies's current Net Income (TTM) was 19. WELL Health Technologies's current Cash Flow from Operations (TTM) was 84. ==> 84 > 19 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=401.039/1459.5286
=0.27477296

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=310.91/1197.29
=0.25967811

WELL Health Technologies's gearing of this year was 0.27477296. WELL Health Technologies's gearing of last year was 0.25967811. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=275.964/333.77
=0.82680888

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=234.864/254.073
=0.92439574

WELL Health Technologies's current ratio of this year was 0.82680888. WELL Health Technologies's current ratio of last year was 0.92439574. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

WELL Health Technologies's number of shares in issue this year was 254.874. WELL Health Technologies's number of shares in issue last year was 250.489. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=483.101/1071.84
=0.45072119

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=276.528/708.37
=0.39037226

WELL Health Technologies's gross margin of this year was 0.45072119. WELL Health Technologies's gross margin of last year was 0.39037226. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=1071.84/1262.166
=0.84920684

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=708.37/1084.707
=0.65305193

WELL Health Technologies's asset turnover of this year was 0.84920684. WELL Health Technologies's asset turnover of last year was 0.65305193. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+0+0+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

WELL Health Technologies has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
WELL Health Technologies (WHTCF) has a Piotroski F-Score of 6 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on WELL Health Technologies and its competitors. This is 50% above median its historical median of 4.00. Over the past decade, WELL Health Technologies' Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, WELL Health Technologies ranks #165 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 25.3%.
Is WELL Health Technologies' Piotroski F-Score too high?
WELL Health Technologies' current Piotroski F-Score of 6 is 50% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. WELL Health Technologies' value of 6 is 20% above this industry median. Based on the distribution chart, WELL Health Technologies ranks #165 out of 652 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, WELL Health Technologies has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does WELL Health Technologies' Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, WELL Health Technologies ranks #165 out of 652 companies for Piotroski F-Score. This puts WELL Health Technologies in the upper half of its industry. The industry median Piotroski F-Score is 5.00. WELL Health Technologies' value of 6 is 20% above this benchmark. Historically, WELL Health Technologies' own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, WELL Health Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WELL Health Technologies's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on WELL Health Technologies and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WELL Health Technologies's current Piotroski F-Score is 6, which is 50% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WELL Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, WELL Health Technologies (WHTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.16, compared to a current price of $2.91 — trading 43.6% below its estimated fair value. The current Piotroski F-Score is 6, which is 50% above median its 10-year median of 4.00 and 20% above the Healthcare Providers & Services industry median of 5.00. WELL Health Technologies' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For WELL Health Technologies (WHTCF), the current Piotroski F-Score is 6 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is WELL Health Technologies (WHTCF) Overvalued in 2026?

Based on GuruFocus' analysis, WELL Health Technologies stock appears to be undervalued. The current stock price of $2.91 is trading 43.6% below its estimated GF Value™ of $5.16. GuruFocus considers WELL Health Technologies to be Possible Value Trap.

Key valuation signals for WHTCF:

  • Piotroski F-Score: 6 (50% above median its 10-year median of 4.00)
  • GF Value™: $5.16 vs. price of $2.91 (43.6% below fair value)
  • GF Score™: 76/100 with 6 warning signs
  • Industry Position: 20% above the Healthcare Providers & Services median (#165 of 652)

No single metric tells the full story. See the WHTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


WELL Health Technologies Business Description

Other Exchanges W7V:GermanyWELL:Canada
Address 375 Water Street, Suite 550, Vancouver, BC, CAN, V6B 5C6
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth; WELL Health USA Patient Services, which derives maximum revenue, includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing; SaaS and Technology Services provides digital health and infrastructure solutions for healthcare providers, including Electronic MedicalRecords (EMRs), patient engagement and eReferral solutions, AI-enabled applications, billing and practice management services, and cybersecurity protection and data privacy solutions; and HEALWELL: AI and data sciences and healthcare software offerings.
76GF Score

Get the complete analysis for WHTCF

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.91
Price
$5.16
GF Value